Background: Knee osteoarthritis (KOA) is one of the most common chronic muscular diseases in old people. The purpose of this meta-analysis was to compare celecoxib and diclofenac sodium in patients with knee osteoarthritis (KOA).
Methods: Randomized controlled trials (RCTs) and clinical controlled trials (CCTs) comparing the use of celecoxib and diclofenac sodium in KOA patients were retrieved from each database from the date of database inception to September 2019. The outcome measurements were the treatment effect, visual analog scale (VAS) score, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) level, and complication rate. The pooled data were evaluated with Review Manager 5.3.5.
Results: The literature will provide a high-quality analysis of the current evidence supporting celecoxib for KOA based on various comprehensive assessments including the treatment effect, visual analog scale (VAS) score, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) level, and complication rate.
Conclusion: This proposed systematic review will provide up-to-date evidence to assess the effect of celecoxib in the treatment for patients with KOA. RESEARCH REGISTRY REGISTRATION NUMBER:: reviewregistry827.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220482 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000019680 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparative Evaluation of Cyclooxygenase Inhibition Profiles Across Various NSAID Forms and Doses: Implications for Efficacy and Adverse Effects.
Pain Ther
December 2024
Department of Anesthesiology and Pain Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan.
Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain disorders and exert pharmacological effects by inhibiting cyclooxygenase (COX). Although previous studies have evaluated the COX inhibitory activity and selectivity of NSAIDs, none has compared COX inhibitory concentrations with the plasma concentrations of clinical doses or investigated the efficacy and adverse effects of different dosage forms. Therefore, in this study we evaluated the COX inhibitory activities and inhibition rates of clinical doses of the various NSAID formulations, especially diclofenac sodium.
View Article and Find Full Text PDFEvaluation of gastric tolerability for long-term use of diclofenac and celecoxib in male albino rats and potential gastroprotective benefits of royal jelly: a randomized controlled trial.
J Complement Integr Med
December 2024
Department of Internal Medicine, Faculty of Medicine, Suez University, Suez, Egypt.
Objectives: Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for pain and inflammation relief. Our study aimed to explore the ulcerogenic effect of long-term diclofenac and celecoxib administration on male albino stomachs, focusing on the possible gastroprotective effect of royal jelly administration.
Methods: Five equal groups of 50 male albino rats.
Short-term outcomes of robotic- television-assisted thoracoscopic segmental lung resection for early-stage non-small-cell lung cancer in the day surgery models.
J Thorac Dis
November 2024
Department of Thoracic Surgery, the First People's Hospital of Changzhou City, Changzhou, China.
Background: At present, few articles compare the differences between robot-assisted thoracic surgeries (RATSs) and video-assisted thoracic surgeries (VATSs) in the day surgery model and there is also little literature on what factors influence delayed discharge from day surgery. This study aims to compare short-term outcomes between RATS and VATS for segmental lung resection in a day surgery setting, and to identify risk factors for delayed discharge.
Methods: A retrospective analysis was performed on 204 patients with early-stage non-small-cell lung cancer (NSCLC) who underwent segmental lung resection via RATS or VATS at the First People's Hospital of Changzhou City from January 2021 to December 2023.
Development of a selective COX-2 inhibitor: from synthesis to enhanced efficacy nano-formulation.
RSC Adv
October 2024
Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University Ismailia Egypt
Non-steroidal anti-inflammatory drugs NSAIDs are widely used for managing various conditions including pain, inflammation, arthritis and many musculoskeletal disorders. NSAIDs exert their biological effects by inhibiting the cyclooxygenase (COX) enzyme, which has two main isoforms COX-1 and COX-2. The COX-2 isoform is believed to be directly related to inflammation.
View Article and Find Full Text PDFNano-strategies for advancing oral drug delivery: Porous silicon particles and cyclodextrin encapsulation for enhanced dissolution of poorly soluble drugs.
Int J Pharm
December 2024
Department of Pharmacy, University of Oslo. Sem Sælands vei 3, 0371 Oslo, Norway.
Article Synopsis
- * Porous silicon nanoparticles can effectively encapsulate APIs in an amorphous state, enhancing their dissolution rates compared to crystalline forms, and a new synthesis method using centrifugal Chemical Vapor Deposition (cCVD) has been developed to facilitate this process.
- * Research showed that cCVD Si particles significantly increased dissolution rates for various model drugs, with additional improvements when drug–cyclodextrin complexes were loaded, suggesting effective strategies for enhancing drug bioavailability.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!